All Stories

  1. Author's Reply to Comments to: Clinical Experience of Switching Anti-VEGF Therapy from Ranimizumab to Aflibercept in Age-Related Choroidal Neovascularization

    Article • European Journal of Ophthalmology, May 2017, SAGE Publications

    Mr George Kampougeris

  2. Clinical Experience of Switching Anti-VEGF Therapy from Ranibizumab to Aflibercept in Age-Related Choroidal Neovascularization

    Article • European Journal of Ophthalmology, March 2016, SAGE Publications

    Mr George Kampougeris